At long last, Amgen/UCB score FDA okay for osteoporosis drug
News
Patients
Delivering the right behavioural ingredients for the moment,...
Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing
Sponsored
How to meet your physicians where they are online
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
Sales & Marketing
Sponsored
The strategic imperative of Integrated Evidence Generation P...
Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.
Digital
AI for the planet, AI for life sciences – with Patrick Leung
Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
R&D
Sponsored
A New Framework to Engineer Breakthrough Value for Medicines
A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Market Access
VuuAI and Amiculum partner to transform content engagement i...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
Category :
News
/